The finished good must fulfil Good Manufacturing Practice (GMP) standards, the products’ marketing authorization and national regulations before it can be released by A Qualified Person (QP) to the relevant market. All repackaged medicine is reviewed on the basis of the products’ and finished goods’ documentation.Here, a unique 2D barcode and anti-tampering device are placed on the pack of medicine to secure the authenticity of the product. Again, the quality is secured with our FMD-handling processes which include both decommissioning and aggregation. The medicine is placed in a new box, specifically produced and designed for the destination market.Unpackaging, production of new boxes and leaflets, and FMD handling: When released by our Quality Assurance (QA) department, the medicine begins the unpackaging and repackaging processes.After this, the medicine goes through the second receipt control called Medicine Control Report (MCR). When the medicine arrives at our facility, it undergoes extensive quality controls, hereunder Delivery Control Report (DCR) and Falsified Medicines Directive (FMD) verification.All our suppliers have been qualified and approved. ![]() ![]() ![]() Then, we source the medicine from countries in the EU and transport it to one of our production facilities in Hungary or the Netherlands.In order to identify customer value, such as lower prices or better availability, we monitor and analyze thousands of products every day.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |